Engineering Viruses to Treat Solid Tumors: A Conversation with Dr. Paul-Peter Tak
In a recent episode of BioTech Nation, Dr. Paul-Peter Tak, CEO of Candel Therapeutics, discussed the company’s innovative approach to cancer treatment using engineered viruses. These viruses are designed to target and treat solid tumors by delivering therapeutic genes and activating the patient’s immune system.
Dr. Tak’s insights shed light on the potential of viral therapies in oncology, highlighting their ability to precisely target cancer cells while sparing healthy tissue. This strategy aims to enhance the efficacy of cancer treatments and improve patient outcomes.
For a more in-depth understanding of this groundbreaking approach, you can listen to the full interview on the BioTech Nation website: Engineering Viruses to Treat Solid Tumors.
Link to the podcast
BioTech Nation … with Dr. Moira Gunn | Engineering Viruses to Treat Solid Tumors… Dr. Paul Peter Tak, CEO of Candel Therapeutics
